Hypercoagulability in celiac disease - An update

Autoimmunity Reviews

Volumn 13, Issue 11, 2014, Pages 1138-1141

  Lerner, Aaron ^a   Blank, Miri ^b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Autoimmunity; Celiac disease; Hypercoagulability; Thromboembolism; Thrombophilia

Indexed keywords

AUTOANTIBODY; CYANOCOBALAMIN; FOLIC ACID; VITAMIN K GROUP; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MTHFR PROTEIN, HUMAN;

ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELIAC DISEASE; CEREBROVASCULAR ACCIDENT; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENDOTHELIAL DYSFUNCTION; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; HYPERCOAGULABILITY; NUTRITIONAL DEFICIENCY; PATHOGENESIS; PREGNANCY COMPLICATION; REVIEW; RISK; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOEMBOLISM; THROMBOPHILIA; GENETICS; MUTATION;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; CELIAC DISEASE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; THROMBOPHILIA;

EID: 84908513854     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.07.004     Document Type: Review

References (67)

1. Lerner A., Blank M., Shoenfeld Y. Celiac disease and autoimmunity. Isr J Med Sci 1996, 32:33-36.
2. Denham J.M., Hill I.D. Celiac disease and autoimmunity: review and controversies. Curr Allergy Asthma Rep 2013, 13:347-353. 10.1007/s11882-013-0352-1.
3. Reif S., Lerner A. Celiac disease and infection. Infections and autoimmunity 2004, 689-692. Elsevier B.V., New York. Y. Shoenfeld, N. Rose (Eds.).
4. Reif S., Lerner A. Tissue transglutaminase - the key player in celiac disease: a review. Autoimmun Rev 2004, 3:40-45.
5. Di Sabatino A., Vanoli A., Giuffrida P., Luinetti O., Solcia E., Corazza G.R. The function of tissue transglutaminase in celiac disease. Autoimmun Rev 2012, 11:746-753. 10.1016/j.autrev.2012.01.007.
6. Shamir R., Eliakim R., Lahat N., Sobel E., Lerner A. ELISA assay of antiendomysial antibodies in the diagnosis of celiac disease: comparison with immunofluorescence assay of anti endomysial antibodies and tissue transglutaminase antibodies. Isr Med Assoc J 2002, 4:594-596.
7. Tonutti E., Bizzaro N. Diagnosis and classification of celiac disease and gluten sensitivity. Autoimmun Rev Apr-May 2014, 13(4-5):472-476. 10.1016/j.autrev.2014.01.043.
8. Rozenberg O., Lerner A., Pacht A., Grinberg M., Reginashvili D., Henig C., et al. A novel algorithm for childhood celiac disease serological diagnosis based upon intestinal biopsies. Crit Rev Allergy Immunol 2012, 42:331-341.
9. Lerner A. New therapeutic strategies for celiac disease. Autoimmun Rev 2010, 9:144-147.
10. Lerner A. Factors affecting the clinical presentation and time diagnosis of celiac disease: the Jerusalem and the West Bank-Gaza experience (editorial). Isr J Med Sci 1994, 30:294-295.
11. Branski D., Ashkenazy A., Frier S., Lerner A., Dinari G., Faber J., et al. Extra intestinal manifestation and associated disorders of celiac disease. Gluten-sensitive enteropathy. From Gastrointest. Res 1992, 164-175. Karger, Basel. D. Branski, P. Rozen, M.F. Kaganoff (Eds.).
12. Zelnik N., Pacht A., Obeid R., Lerner A. Range of neurological disorders in patients with celiac disease. Pediatrics 2004, 113:1672-1676.
13. Bushara K.O. Neurologic presentation of celiac disease. Gastroenterology 2005, 128(Suppl. 1):S92-S97.
14. Chang H.H., Chiang B.L. The diagnosis and classification of autoimmune coagulopathy: an updated review. Autoimmun Rev 2014, 13:587-590. 10.1016/j.autrev.2014.01.032.
15. Anderson J.A.M., Weitz J.I. Hypercoagulable states. Crit Care Clin 2011, 27:933-952.
16. Bertolaccini M.L., Amengual O., Andreoli L., Atsumi T., Chighizola C.B., Forastiero R., et al. 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends. Autoimmun Rev 2014, [pii: S1568-9972(14)00120-7]. 10.1016/j.autrev.2014.05.001.
17. Lerner A., Agmon-Levin N., Shapira Y., Gilburd B., Reuter S., Lavi L., et al. The thrombophylic network of autoantibodies in celiac disease. BMJ Med 2013, 11:89-95.
18. Cugno M., Gualtierotti R., Tedeschi A., Meroni P.L. Autoantibodies to coagulation factors: from pathophysiology to diagnosis and therapy. Autoimmun Rev 2014, 13:40-48. 10.1016/j.autrev.2013.08.001.
19. Lipinski S., Bremer L., Lammers T., Thieme F., Schreiber S., Rosenstiel P. Coagulation and inflammation. Molecular insights and diagnostic implications. Hamostaseologie 2011, 31:94-104.
20. Rubio-Jurado B., Iniguez-Franco P., Reyes P.A., Robles G., Salazar-paramo M., Zavala-Cerna G., et al. The clinical significance of coagulation and the inflammatory response in autoimmunity. Clin Rev Allergy Immunol 2012, 42:172-180.
21. Sitia S., Gianturco L., Tomasoni L., Turiel M. Role of cardiovascular imaging in systemic autoimmune diseases. World J Cardiol 2010, 2:237-242.
22. Broder A., Chan J.J., Putterman C. Dendritic cells: an important link between antiphospholipid antibodies, endothelial dysfunction, and atherosclerosis in autoimmune and non-autoimmune diseases. Clin Immunol 2013, 146:197-206.
23. Zinger H., Sherer Y., Shoenfeld Y. Atherosclerosis in autoimmune rheumatic diseases - mechanism and clinical findings. Clin Rev Allergy Immunol 2009, 37:20-28.
24. Biji M. Endothelial activation, endothelial dysfunction and premature atherosclerosis in systemic autoimmune diseases. Neth J Med 2003, 61:273-277.
25. Murdaca G., Colombo B.M., Cagnati P., Gulli R., Spano F., Puppo F. Endothelial dysfunction in rheumatic autoimmune diseases. Atherosclerosis 2012, 224:309-317.
26. Koniari I., Siminelakis S.N., Baikoussis N.G., Papadopoulos G., Goudevenos J., Apostolakis E.A. Antiphospholipid syndrome; its implication in cardiovascular disease; a review. J Cardiothorac Surg 2010, 5:101-110.
27. Giannakopoulos B., Krilis S. The pathogenesis of the antiphospholipid syndrome. NEJM 2013, 368:1033-1044.
28. John M.L., Scharrer I. Autoimmune disorders in patients with idiopathic thrombotic thrombocytopenic purpura. Hamostaseologie 2012, 32:86-89.
29. Chhabra S., Tenorio G. Thrombotic thrombocytopenia purpura precipitated by thyrotoxicosis. J Clin Apher 2012, 27:265-266.
30. Turemen E.E., Cetinarslan B., Sahin T., Canturk Z., Tarkun L. Endothelial dysfunction and low grade chronic inflammation in subclinical hypothyroidism due to autoimmune thyroiditis. Endocr J 2011, 58:349-359.
31. Deutscmann A., Schlagenhauf A., Leschnik B., Hoffmann K.M., Hauer A., Muntean W. Increased procoagulant function of microparticles in pediatric inflammatory bowel disease: role in increased thrombin generation. J Pediatr Gastroenterol Nutr 2013, 56:401-407.
32. Stadnicki A. Thrombin generation and microparticles in inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2013, 56:343.
33. Nylund C.M., Goudie A., Garza J.M., Crouch G., Denson L.A. Venous thrombotic events in hospitalized children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2013, 56:485-491.
34. El Moutawakil B., Chourkani N., Sibai M., Moutaouakil F., Rafai M., Bourezgui M., et al. Celiac disease and ischemic stroke. Rev Neurol (Paris) 2009, 165:962-966.
35. Audia S., Duchene C., Samson M., Muller G., Bielefeld P., Ricolfi F., et al. Stroke in young adults with celiac disease. Rev Med Interne 2008, 29:228-231.
36. Goodwin F.C., Beattie R.M., Millar J., Kirkham F.J. Celiac disease and childhood stroke. Pediatr Neurol 2004, 31:139-142.
37. Belfkih R., Souirti Z., Chtaou N., Messouak O., Belahsen F. Accident vasculaire cerebral ischemique revelant une maladie coeliaque. Pan Afr Med J 2010, 5:2-7.
38. Ludvigsson J.F., West J., Card T., Appelros P. Risk of stroke in 28000 patients with celiac disease: a nationwide cohort study in Sweden. J Stroke Cerebrovasc Dis 2012, 21:860-867.
39. Ciacci C., Tortora R., Scudiero O., Di Fiore R., Salvatore F., Castaldo G. Early pregnancy loss in celiac women: the role of genetic markers of thrombophilia. Dig Liver Dis 2009, 41:717-720.
40. Baryshnikov E.N., Krums L.M., Vorobeva N.N., Parfenov A.L. Lower extremity deep vein thrombosis associated with gluten-sensitivity celiac disease. Ter Arkh 2010, 82:52-54.
41. Kremer Hovinga J.A., Baerlocher G., Wuillemin W.A., Solenthaler M. Deep venous thrombosis of the leg in acquired thrombophilia-hyperhomocysteinemia as a sequela of undetected celiac disease. Rev Therapeutique 1999, 56:519-522.
42. McNeill A., Duthie F., Galloway D.J. Small bowel infarction in a patient with celiac disease. J Clin Pathol 2006, 59:216-218.
43. Emilsson L.E., Smith J.G., West J., Melander O., Ludvigsson J.F. Increased risk of atrial fibrillation in patients with celiac disease: a nationwide cohort study. Eur Heart J 2011, 32:2430-2437.
44. Afredj N., Metatla S., Faraoun S.A., Nani A., Guessab N., Benhalima M., et al. Association of Budd-Chiari syndrome and celiac disease. Gastroenterol Clin Biol 2010, 34:621-624.
45. Karoui S., Sfar S., Kallel M., Boubaker J., Makni S., Filali A. Antiphospholipid syndrome revealed by portal vein thrombosis in a patient with celiac disease. Rev Med Interne 2004, 25:471-473.
46. Makhdoom Z., Randall N.W. Dilated cardiomyopathy due to anticardiolipin syndrome in association with celiac sprue. J Clin Gastroenterol 2000, 31:91-92.
47. Turcu A., Bonnotte B., Fein F., Martin F., Chauffert B., Lorcerie B. Association of celiac disease and antiphospholipid syndrome. Presse Med 1998, 27:1789.
48. Gabrielli M., Santoliquido A., Gasbarrini G., Pola P., Gasbarrini A. Latent celiac disease, hyperhomocysteinemia and pulmonary thromboembolism: a close link. Thromb Haemost 2003, 89:203-204.
49. Marteau P., Cadranel J.F., Messing B., Gargot D., Valla D., Rambaud J.C. Association of hepatic vein obstruction and celiac disease in North African subjects. J Hepatol 1994, 20:650-653.
50. Andres E., Pflumio F., Knab M.C., Muller M., Ott C., Ubrich M. Splenic thrombosis and celiac disease: a fortuitous association. Presse Med 2000, 29:1933-1934.
51. Dogan M., Peker E., Akbayram S., Bektas M.S., Basaranoglu M., Cesur Y. Cerebral venous sinus thrombosis in 2 children with celiac disease. Clin Appl Thromb Hemost 2011, 17:466-469.
52. Lerner A., Blank M., Shoenfeld Y. Increased prevalence of autoantibodies in celiac disease. Dig Dis Sci 1998, 43:723-726.
53. Shaoul R., Lerner A. Associated autoantibodies in celiac disease. Autoimmun Rev 2007, 6:559-565.
54. Swissa M., Lerner A., Sasaki T., Sela E., Blank M., Shoenfeld Y. The diverse pathogenic potential of anti-DNA antibodies from various sources to induce experimental systemic lupus erythematosus. Pathobiology 1996, 64:32-39.
55. Shamir R., Shoenfeld Y., Blank M., Eliakim R., Lahat N., Sobel E., et al. The prevalence of coeliac disease antibodies in patients with the antiphospholipid syndrome. Lupus 2003, 12:394-399.
56. Okuma H., Kitagawa Y., Ishikawa T., Takagi S. Study of phosphatidylserine-dependent anti-prothrombin antibody in cerebral infarction. Intern Med 2009, 48:1351-1355.
57. Bertolaccini M.L., Atsumi T., Koike T., Hughes G.R., Khamashta M.A. Antiprothrombin antibodies detected in two different assay systems. Prevalence and clinical significance in systemic lupus erythematosus. Thromb Haemost 2005, 93:289-297.
58. Hoxha A., Ruffatti A., Tonello M., Bontadi A., Salvan E., Banzata A., et al. Antiphosphatidylserine/prothrombin antibodies in primary antiphospholipid syndrome. Lupus 2012, 21:787-789.
59. Hoxha A., Ruffatti A., Pittoni M., Bontadi A., Tonello M., Salvan E., et al. The clinical significance of autoantibodies directed against prothrombin in primary antiphospholipid syndrome. Clin Chim Acta 2012, 413:911-913.
60. Hozyasz K.K., Mostowska A., Szaflarska-Poplawaka A., Lianeri M., Jagodzinski P.P. Polymorphic variants of genes involved in homocysteine metabolism in celiac disease. Mol Biol Rep 2012, 39:3123-3130.
61. Wilcox G.M., Mattia A.R. Celiac sprue, hyperhomocysteinemia, and MTHFR gene variants. J Clin Gastroenterol 2006, 40:596-601.
62. Dickey W., Ward M., Whittle C.R., Kelly M.T., Pentieva K., Horigan G., et al. Homocysteine and related B-vitamin status in celiac disease: effects of gluten exclusion and histological recovery. Scand J Gastroenterol 2008, 43:682-688.
63. Casella G., Bassotti G., Villanacci V., Di Bella C., Pagni F., Corti G.L., et al. Is hyperhomocysteinemia relevant in patients with celiac disease?. World J Gastroenterol 2011, 17:2941-2944.
64. Hallert C., Grant C., Grehn S., Grännö C., Hultén S., Midhagen G. Evidence of poor vitamin status in celiac patients on a gluten-free diet for 10years. Aliment Therap 2002, 16:1333-1339.
65. Coleman N.S., Foley S., Dunlop S.P., Wheatcroft J., Blackshaw E., Perkins A.C., et al. Abnormalities of serotonin metabolism and their relation to symptoms in untreated celiac disease. Clin Gastroenterol Hepatol 2006, 4:874-881.
66. Berthoux E., Fabien N., Chayvialle J.A., Ninet J., Durieu I. Adult celiac disease with thrombosis: a case series of seven patients. Role of thrombophilic factors. Rev Med Interne 2011, 32:600-604.
67. Sjober K., Eriksson S., Tenngart B., Roth E.B., Leffler H., Stenberg P. Factor XIII and tissue transglutaminase antibodies in coeliac and inflammatory bowel disease. Autoimmunity 2002, 35:357-364.